Zacks Research Issues Positive Outlook for Integer Earnings

Integer Holdings Co. (NYSE:ITGR) – Equities research analysts at Zacks Research increased their FY2024 earnings per share (EPS) estimates for Integer in a research report issued to clients and investors on Thursday, November 14th. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will earn $5.32 per share for the year, up from their prior forecast of $5.28. The consensus estimate for Integer’s current full-year earnings is $5.34 per share. Zacks Research also issued estimates for Integer’s Q4 2024 earnings at $1.45 EPS, Q1 2025 earnings at $1.30 EPS, Q2 2025 earnings at $1.45 EPS, Q4 2025 earnings at $1.69 EPS, FY2025 earnings at $5.99 EPS, Q1 2026 earnings at $1.63 EPS and Q2 2026 earnings at $1.57 EPS.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.07. The business had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period last year, the company earned $1.27 EPS.

Other analysts have also issued research reports about the stock. Piper Sandler reaffirmed an “overweight” rating and set a $140.00 price target (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th. KeyCorp upped their price target on Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research note on Tuesday, October 15th. Truist Financial cut their price objective on Integer from $150.00 to $147.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Citigroup upped their target price on shares of Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a research report on Tuesday, October 1st. Finally, Bank of America boosted their price target on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $139.75.

Integer Price Performance

Shares of ITGR stock opened at $133.18 on Monday. The firm’s 50-day moving average is $129.20 and its two-hundred day moving average is $122.66. Integer has a 12 month low of $84.75 and a 12 month high of $140.91. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. The company has a market capitalization of $4.47 billion, a PE ratio of 41.10, a price-to-earnings-growth ratio of 1.91 and a beta of 1.09.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Contravisory Investment Management Inc. grew its holdings in Integer by 55.9% during the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 80 shares in the last quarter. Huntington National Bank increased its holdings in Integer by 8,933.3% in the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after buying an additional 268 shares during the last quarter. Quest Partners LLC raised its stake in Integer by 3,688.9% in the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 332 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Integer by 60.9% during the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock worth $43,000 after buying an additional 142 shares during the last quarter. Finally, Innealta Capital LLC acquired a new position in shares of Integer during the 2nd quarter worth about $110,000. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.